← SynDRA

RILZABRUTINIB

SynDRA canonical compound SYN0038412 — structure-anchored drug synonym record

All known targets

• BTK

Mechanisms of action (all sources)

• BTK INHIBITOR
• Tyrosine-protein kinase BTK inhibitor
• Bruton's tyrosine kinase (BTK) inhibitor

Cross-references

• PubChem CID: 73388818
• ChEMBL: CHEMBL3702854
• DrugBank: DB17709
• KEGG: D11873
• RxNorm: 2722398
• PDB: R1L
• Wikipedia: Rilzabrutinib
• TTD: D0GH7L

Synonyms

• PRN-1008
• PRN1008
• Rilzabrutinib, (.alpha.e,3s)-
• (.ALPHA.E,3S)-
• (E)-PRN1008
• (E)-RILZABRUTINIB
• LCFFREMLXLZNHE-GBOLQPHISA-N
• SCHEMBL15506003
• BDBM143212
• US8940744, 31
• (R,E)-2-(3-(4-amino-3-(2-fluoro-4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidine-1-carbonyl)-4-methyl-4-(4-(oxetan-3-yl)piperazin-1-yl)pent-2-enenitrile
• PRN 1008
• Rilzabrutinib [INN]
• Rilzabrutinib [USAN]
• NWN58M4F5T
• Example 31 [WO2014039899]
• Example 31 (WO2014039899)
• RefChem:883642
• Rilzabrutinib, (E)-
• 5G1WE425BI
• PRN1008, (E)-
• PRN-1008, (E)-
• Wayrilz
• Wayrilz (TN)
• UNII-NWN58M4F5T
• Rilzabrutinib [USAN:INN]
• Rilzabrutinib (PRN1008)
• UNII-5G1WE425BI
• GTPL9993
• orb1309216
• Rilzabrutinib (JAN/USAN/INN)
• SCHEMBL29368877
• SCHEMBL29564512
• C36H40FN9O3
• EX-A4524
• BDBM50557485
• EBC-64029
• EBC-84050
• NSC812901